CN1698854A - Tablet for treating urination difficulty caused by prostate hyperplasia and its preparation process - Google Patents
Tablet for treating urination difficulty caused by prostate hyperplasia and its preparation process Download PDFInfo
- Publication number
- CN1698854A CN1698854A CN 200510031665 CN200510031665A CN1698854A CN 1698854 A CN1698854 A CN 1698854A CN 200510031665 CN200510031665 CN 200510031665 CN 200510031665 A CN200510031665 A CN 200510031665A CN 1698854 A CN1698854 A CN 1698854A
- Authority
- CN
- China
- Prior art keywords
- tablet
- radix
- prostate hyperplasia
- difficulty caused
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed is a tablet for treating urination difficulty caused by prostate hyperplasia whose constituents include astragalus root, poria cocos wolf each 9-27%, wood louse, cluster mallow fruit, cassia twig, fruit of citron each 3-9%, peach kernel 4-11%, epimeddium, giant knotweed rhizome, cyathula root each 5-14%, bupleurum root 2-6%. The preparation comprises charging the medicinal materials into water, boiling three times, merging the grilling liquid, filtrating, concentrating the filtrate to clear grease with specific gravity of 1.10-1.40 (60 deg. C), drying, disintegrating into fines, charging right amount of adjuvant, bed blending, palletizing, drying and tabletting.
Description
Technical field:
The present invention relates to a kind of Chinese medicinal tablet and preparation technology's method thereof, relate in particular to tablet for treating urination difficulty caused by prostate hyperplasia and preparation method thereof.
Background technology:
Tablet is a kind of novel medicament dosage form, according to the relevant laws and regulations of China's drug control, changes dosage form and manages as new drug research.The original dosage form of this product is a capsule, has listed the national drug standards in.
Existing 'Qianlielongbitong ' capsule is a kind of Chinese medicine preparation for the treatment of the prostatic hyperplasia disease, its technology features be with prescription Chinese crude drug water carry, concentrate, drying, pulverizing, encapsulated, promptly.
The existing capsular medicine stability of 'Qianlielongbitong ' is relatively poor, and inconvenience is produced, preserves, carries and used to the production cost height.
Summary of the invention:
It is good to the purpose of this invention is to provide a kind of medicine stability, production cost is low, produce, preserve, carry and use more convenient, be used for the treatment of Chinese medicine preparation of prostatic hyperplasia disease and preparation method thereof, overcome the above-mentioned drawback of prior art, improve the quality and the curative effect of product, satisfy the needs of medical treatment better.
Technical solution of the present invention is a kind of tablet for treating urination difficulty caused by prostate hyperplasia, it is a kind of Chinese patent medicine that is used for the treatment of the prostatic hyperplasia disease, it is characterized in that it be constituent be the Radix Astragali, Poria each 9～27%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 3～9%, Semen Persicae 4～11%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 5～14%, the tablet of Radix Bupleuri 2～6%.
The constituent optimum weight percentage ratio of tablet for treating urination difficulty caused by prostate hyperplasia be the Radix Astragali, Poria each 18.4%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 6.1%, Semen Persicae 7.4%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 9.2%, Radix Bupleuri 3.7%.
The preparation method of tablet for treating urination difficulty caused by prostate hyperplasia is:
(1) getting main medicine constituent and percentage by weight thereof is:
The Radix Astragali, Poria each 9～27%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 3～9%, Semen Persicae 4～11%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 5～14%, Radix Bupleuri 2～6%;
(2) get said medicine and add the decocting digestion 1～3 time, each amount of water is 6～14 times of amounts of medication amount, and each 1～3 hour, medicinal liquid merged, and filtered; Optimised process is for adding the decocting digestion 3 times, and the 1st time 3 hours, the 2nd, 3 time each 2 hours;
(3) filtrate with above-mentioned (2) gained is concentrated into the thick paste that relative density is 1.10～1.40 (60 ℃);
(4) with the thick paste of above-mentioned (3) gained, drying, dried cream powder was broken into 60～160 purpose fine powders, and was best for superfine powder was broken into 200～300 purpose fine powders, standby;
(5) with the fine powder and the appropriate amount of auxiliary materials of above-mentioned (4) gained, mixing is granulated, drying, and tabletting, promptly.
(6) used adjuvant can be in the preparation method: any or multiple during micropowder silica gel, starch, dextrin, magnesium stearate, essence, Pulvis Talci, sucrose, microcrystalline Cellulose, carboxymethyl starch are received.
Specific embodiments:
The present invention further specifies as follows in conjunction with specific embodiments:
Tablet for treating urination difficulty caused by prostate hyperplasia is a kind of Chinese patent medicine for the treatment of the prostatic hyperplasia disease, and its constituent is: the Radix Astragali, Eupolyphaga Seu Steleophaga, Fructus Malvae, Semen Persicae, Ramulus Cinnamomi, Herba Epimedii, Radix Bupleuri, Poria, Rhizoma Polygoni Cuspidati, Fructus Aurantii, Radix Cyathulae.It has the QI invigorating warming YANG, and the activating blood and promoting diuresis function is used for the treatment of the difficulty in urination due to the blood stasis due to renal deficiency, and disease is seen frequent micturition, urinate in delaying, require great effort, and dribble of urine, soreness of the waist and knees, prostatic hyperplasia are seen above-mentioned patient.
A kind of optimum implementation of 'Qianlielongbitong ' piece preparation method is:
(1) get it filled thing constituent and optimum weight percentage ratio thereof is: the Radix Astragali, Poria each 18.4%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 6.1%, Semen Persicae 7.4%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 9.2%, Radix Bupleuri 3.7%;
(2) above medicine decocts with water three times, and 3 hours for the first time, second and third time each 2 hours, collecting decoction, filter, filtrate is concentrated into the thick paste that relative density is 1.10～1.40 (60 ℃), drying, and dried cream powder is broken into fine powder, adds appropriate amount of auxiliary materials, mixing is granulated, drying, and tabletting, promptly.
Advantage of the present invention is: tablet for treating urination difficulty caused by prostate hyperplasia is compared with existing Qianlielongbitong Capsules, can guarantee better medicine Stability, reduce production costs, be beneficial to production, preserve, carry and use, being used for the hyperplasia of prostate disease can be better Satisfy needs of medical treatment.
Claims (3)
1, a kind of tablet for treating urination difficulty caused by prostate hyperplasia, it is a kind of Chinese medicine preparation for the treatment of the prostatic hyperplasia disease, it is characterized in that it be constituent be the Radix Astragali, Poria each 9～27%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 3～9%, Semen Persicae 4～11%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 5～14%, the tablet of Radix Bupleuri 2～6%.
2, a kind of preparation method of tablet for treating urination difficulty caused by prostate hyperplasia is characterized in that:
(1) get it filled thing constituent and percentage by weight thereof is:
The Radix Astragali, Poria each 9～27%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 3～9%, Semen Persicae 4～11%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 5～14%, Radix Bupleuri 2～6%;
(2) get said medicine and decoct with water 1～3 time, each amount of water is 6～14 times of amounts of medication amount, each 1～3 hour; The best is: decoct with water 3 times, the 1st time 3 hours, the 2nd, 3 time each 2 hours, amount of water was 8～10 times of medication amount; Decocting liquid merges, and filters;
(3) filtrate with above-mentioned (2) gained is concentrated into the thick paste that relative density is 1.10～1.40 (60 ℃);
(4) with the thick paste of above-mentioned (3) gained, drying, dried cream powder was broken into the fine powder of 60～160 mesh sieves, and was best for superfine powder was broken into 200～300 purpose fine powders, standby;
(5) with the fine powder and the appropriate amount of auxiliary materials of above-mentioned (4) gained, mixing is granulated, drying, and tabletting, promptly.
3, tablet for treating urination difficulty caused by prostate hyperplasia according to claim 1 is characterized in that the optimum weight percentage ratio of its constituent is:
The Radix Astragali, Poria each 18.4%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 6.1%, Semen Persicae 7.4%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 9.2%, Radix Bupleuri 3.7%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510031665 CN1698854A (en) | 2005-06-06 | 2005-06-06 | Tablet for treating urination difficulty caused by prostate hyperplasia and its preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510031665 CN1698854A (en) | 2005-06-06 | 2005-06-06 | Tablet for treating urination difficulty caused by prostate hyperplasia and its preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1698854A true CN1698854A (en) | 2005-11-23 |
Family
ID=35475208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510031665 Pending CN1698854A (en) | 2005-06-06 | 2005-06-06 | Tablet for treating urination difficulty caused by prostate hyperplasia and its preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1698854A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103230458A (en) * | 2013-05-09 | 2013-08-07 | 武汉市健恒药业有限公司 | Method for preparing prostate Longbitong tablet |
| CN108295139A (en) * | 2018-04-09 | 2018-07-20 | 江苏颐海药业有限责任公司 | A kind of preparation method of tablet for treating urination difficulty caused by prostate hyperplasia |
| CN112494560A (en) * | 2020-11-27 | 2021-03-16 | 江苏颐海药业有限责任公司 | Preparation process of Chinese patent medicine for treating prostate disease |
-
2005
- 2005-06-06 CN CN 200510031665 patent/CN1698854A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103230458A (en) * | 2013-05-09 | 2013-08-07 | 武汉市健恒药业有限公司 | Method for preparing prostate Longbitong tablet |
| CN108295139A (en) * | 2018-04-09 | 2018-07-20 | 江苏颐海药业有限责任公司 | A kind of preparation method of tablet for treating urination difficulty caused by prostate hyperplasia |
| CN112494560A (en) * | 2020-11-27 | 2021-03-16 | 江苏颐海药业有限责任公司 | Preparation process of Chinese patent medicine for treating prostate disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101940740B (en) | Chinese medicinal preparation for treating anemia | |
| CN1586544A (en) | Medicinal wine and its producing method | |
| CN100509033C (en) | Kidney benefiting hypoglycemic medicine composition and prepn process thereof | |
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN1739611A (en) | Stasis relieving oral liquid for treating rhinitis and its prepn | |
| CN102488743A (en) | Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation | |
| CN1054370A (en) | A kind of manufacture method of kidney-tonifying health-care medicament | |
| CN1698854A (en) | Tablet for treating urination difficulty caused by prostate hyperplasia and its preparation process | |
| CN1839981A (en) | Gynecological inflammation resisting dispersion tablet and its preparation method | |
| CN102114189A (en) | Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder | |
| CN101549075B (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia and preparation method thereof | |
| CN101167951A (en) | Traditional Chinese medicinal composition for treating diabetes and its preparation method | |
| CN101664504A (en) | Medicament for treating diabetes and preparation method thereof | |
| CN101219187A (en) | Method for preparing Chinese medicine of condensed pill for preventing brain decline | |
| CN114344421A (en) | Medicinal and edible pure Chinese herbal medicine composition for treating hypertension and preparation method thereof | |
| CN1823925A (en) | New preparation for treating constrained liver qi | |
| CN1739731A (en) | Gynecopathy treating medicine prepn and its prepn process | |
| CN102885953A (en) | Traditional Chinese medicine preparation for tonifying kidney and spleen and preparation process thereof | |
| CN1170554C (en) | Help producing saliva and slaking thirst traditional Chinse medicine powder | |
| CN1517115A (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
| CN1292272A (en) | Medicine for curing diabetes and its preparation method | |
| CN1593528A (en) | Dispersible tablet for treating urination difficulty and its preparation method | |
| CN1695639A (en) | Chinese traditional medicine for treating dysmenorrhea and irregular menses, and preparation method | |
| CN1600359A (en) | Capsule for curing high blood fat and preparation method | |
| CN1759867A (en) | Granules of Chinese traditional medicine for treating women's irregular menses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |